ˇ
W. Oberhauser, P. Steˇpnicˇka et al.
FULL PAPER
10.6 Hz; C-14, C-16, C-20 and C-22), 129.6 (d, 1JC,P = 58.5 Hz, C- (d, JP,C = 5.6 Hz, C-4) (C-1 partially overlapped), 71.79 (d, JP,C
3
3
12 and C-18), 131.37 and 131.70 (d; 4JC,P = 1.5 and 2.1 Hz, respec-
tively; C-15 and C-21), 132.17 and 134.17 (d; JC,P = 11.9 and
= 5.6 Hz, C-3), 74.81 (d, 2JP,C = 7.8 Hz, C-5), 80.57 (s, C-25), 89.19
2
2
2
(d, JP,C = 20.0 Hz, C-2), 127.99 (d, JP,C = 7.4 Hz, C-30), 128.44
12.2 Hz, respectively; C-13, C-17, C-19 and C-23), 172.05 (s, C-11) (d; 3JP,C = 10.7 Hz; C-15, C-17, C-21 and C-23), 130.43 and 131.07
ppm. 31P{1H} NMR (161.98 MHz, CD2Cl2, 25 °C): δ = 16.79 ppm.
(d; JP,C = 1.9 and 1.5 Hz, respectively; C-16 and C-22), 130.61 (d,
1JP,C = 50.0 Hz, C-13 and C-19), 133.16 and 134.13 (d; 2JP,C = 12.2
and 12.6 Hz, respectively; C-14, C-18, C-20 and C-24), 133.21 (d,
2JP,C = 8.9 Hz, C-31), 174.38 (s, C-12) ppm. 31P{1H} NMR
4
Synthesis of 1c: A procedure analogous to that described above for
1a that used HLc instead of HLa was employed to give 1c as an
orange crystalline solid. Yield 99.5 mg (74%). C33H35FeO3PPd
(672.6): calcd. C 58.93, H 5.20; found C 59.02, H 5.31. Dia-
stereoisomer ratio A/B
(400.13 MHz, CD2Cl2, 25 °C): δ = 1.80–2.85 (9 H; 25-H, 27-H, 28-
(161.98 MHz, CD2Cl2, 25 °C): δ = 18.32 ppm. Diasteroisomer B:
1H NMR (400.13 MHz, CD2Cl2, 25 °C): δ = 0.87 (t, JH,H
=
3
=
3:2. Diasteroisomer A: 1H NMR
7.0 Hz, 3 H, 36-H), 1.11 (dd, 2JH,H = 7.2 and JH,H = 1.2 Hz, 1 H,
3
2
3
29-H), 1.38 (dd, JH,H = 9.9 and JH,H = 1.6 Hz, 1 H, 29Ј-H), 1.86
(m, 2 H, 32-H), 2.38 (d, 2JH,H = 5.5 Hz, 33-H), 2.70–2.92 (5 H; 11-
H, 28-H and 34-H), 2.92–3.02 (2 H, 26-H and 27-H), 3.15 (m, 1
H, 35-H), 3.36 (m, 1 H, 35Ј-H), 3.61 (m, 1 H, 25-H), 3.74 (m, 1 H,
2
H, 31-H and 32-H), 2.58 (s, 3 H, 33-H), 3.22 (d, JH,H = 12.7 Hz,
2
1 H, 11-H), 3.66 (d, JH,H = 12.7 Hz, 1 H, 11Ј-H), 3.89 (s, 5 H, 6-
H–10-H), 4.02 (m, 1 H, 4-H), 4.34 (m, 1 H, 5-H), 4.55 (m, 1 H, 3-
H), 6.16 (m 1 H, 30-H), 6.77 (m, 1 H, 29-H), 7.24–8.20 (m, overlap-
ping signals, 14-H–18-H and 20-H–24-H) ppm. 13C{1H} NMR
(100.62 MHz, CD2Cl2, 25 °C): δ = 25.09 (s, C-31), 28.09 (s, C-28),
30.93 (s, C-27), 35.76 (s, C-32), 39.34 (s, C-11), 42.82 (s, C-25),
3
3-H), 4.04 (s, 5 H, 6-H–10-H), 4.29 (t, JH,H = 2.4 Hz, 1 H, 4-H),
4.55 (m, 1 H, 5-H), 6.69 (m, 1 H, 31-H), 7.10 (m, 1 H, 30-H), 7.45–
7.98 (m, overlapping signals, 14-H–18-H and 20-H–24-H) ppm.
13C{1H} NMR (100.62 MHz, CD2Cl2, 25 °C): δ = 15.23 (s, C-36),
31.95 (s, C-34), 35.47 (s, C-29), 39.15 (s, C-27), 39.29 (s, C-11),
41.22 (s, C-33), 51.17 (s, C-32), 53.0 (s, C-26), 57.27 (s, C-28), 63.49
(s, C-35), 68.91 (d, JP,C = 5.7 Hz, C-4), 70.05 (C-1, partially over-
lapped), 70.70 (br, C-3), 74.34 (d, JP,C = 8.2 Hz, C-5), 81.30 (s, C-
25), 89.35 (d, JP,C = 20 Hz, C-2), 126.03 (d, JP,C = 7.2 Hz, C-30),
128.16 and 128.27 (d; JP,C = 10.7 and 11.5 Hz, respectively; C-15,
2
1
55.73 (s, C-33), 69.33 (d, JC,P = 5.2 Hz, C-5), 70.18 (d, JC,P
=
=
3
51.1 Hz, C-1), 70.44 (s, C-4), 71.07 (s, C-6–C-10), 74.75 (d, JC,P
8.5 Hz, C-3), 81.37 (s, C-26), 89.54 (d, 2JC,P = 18.9 Hz, C-2), 121.39
3
2
2
(d, JC,P = 7.6 Hz, C-30), 124.55 (d, JC,P = 9.7 Hz, C-29), 128.34
2
3
and 128.92 (d; JC,P = 9.9 and 11.6 Hz, respectively; C-15, C-17,
2
2
C-21 and C-23), 129.70 and 131.84 (d, 1JC,P = 1.5 Hz, C-16 and C-
3
1
22), 130.98 and 133.45 (d; JC,P = 51.5 and 48.1 Hz, respectively;
C-13 and C-19), 131.87 and 135.64 (d; JC,P = 14.4 Hz; C-14, C-
4
C-17, C-21 and C-23), 130.02 and 131.15 (d, JP,C = 1.5 Hz, C-16
2
1
and C-22), 130.61 (d, JP,C = 50.0 Hz, C-13 and C-19), 132.40 (d,
18, C-20 and C-24), 175.09 (s, C-12) ppm. 31P{1H} NMR
(161.98 MHz, CD2Cl2, 25 °C): δ = 15.52 ppm. Diasteroisomer B:
1H NMR (400.13 MHz, CD2Cl2, 25 °C): δ = 1.80–2.85 (9 H; 25-
H, 27-H, 28-H, 31-H and 32-H), 2.59 (s, 3 H, 33-H), 3.01 (d, 2JH,H
2JP,C = 8.9 Hz, C-31), 133.09 and 134.78 (d; JP,C = 11.5 and
2
13.3 Hz, respectively; C-14, C-18, C-20 and C-24), 174.63 (s, C-12)
ppm. 31P{1H} NMR (161.98 MHz, CD2Cl2, 25 °C): δ = 16.84 ppm.
2
= 13.1 Hz, 1 H, 11-H), 3.11 (d, JH,H = 13.1 Hz, 1 H, 11Ј-H), 4.02
Synthesis of 1d: A procedure analogous to that described above for
1a that used HLd instead of HLa was employed to give 1d as
orange microcrystals. Yield 151.3 mg (75%). C33H35FeO3PPd
(672.6): calcd. C 58.93, H 5.20; found C 59.05, H 5.41. Dia-
(m, 1 H, 4-H), 4.21 (s, 5 H, 6-H–10-H), 4.34 (m, 1 H, 5-H), 4.52
(m, 1 H, 3-H), 6.43 (m, 1 H, 30-H), 6.61 (m, 1 H, 29-H), 7.24–8.20
(m, overlapping signals, 14-H–18-H and 20-H–24-H) ppm.
13C{1H} NMR (100.62 MHz, CD2Cl2, 25 °C): δ = 25.30 (s, C-31),
28.57 (s, C-28), 31.37 (s, C-27), 35.22 (s, C-32), 38.02 (s, C-11),
40.48 (s, C-25), 55.40 (s, C-33), 68.64 (d, 2JC,P = 5.6 Hz, C-5), 71.25
stereoisomer ratio A/B
=
4:3. Diasteroisomer A: 1H NMR
(400.13 MHz, CD2Cl2, 25 °C): δ = 1.68–2.68 (9 H, 25-H, 27-H, 28-
2
H, 31-H and 32-H), 2.71 (s, 3 H, 33-H), 3.14 (dd, JH,P = 14.4 and
3
(s, C-6–C-10), 71.48 (s, C-4), 74.39 (d, JC,P = 8.5 Hz, C-3), 81.37
2JH,H = 12.8 Hz, 1 H, 11-H), 3.86 (br. s, 1 H, 5-H) (5-H, overlapped
(s, C-26), 89.02 (d, 2JC,P = 21.0 Hz, C-2), 122.16 (d, 2JC,P = 8.3 Hz,
C-30), 124.00 (d, 2JC,P = 8.5 Hz, C-29), 128.64 and 128.78 (d; 3JC,P
= 14.4 and 11.6 Hz, respectively; C-15, C-17, C-21 and C-23),
2
2
signal), 4.11 (s, 5 H, 6-H–10-H), 4.33 (dd, JH,P = 5.6 and JH,H
=
12.8 Hz, 1 H, 11Ј-H), 4.71 (br. s, 1 H, 3-H), 6.48 (m 1 H, 30-H),
(29-H, overlapped signal), 7.22–7.92 (m, 14-H–18-H and 20-H–24-
H) ppm. 13C{1H} NMR (100.62 MHz, CD2Cl2, 25 °C): δ = 25.28
4
130.85 and 131.12 (d, JC,P = 1.5 Hz, C-16 and C-22), 131.12 (d,
2
JC,P = 1.9 Hz, CHp PPh2), 133.36 and 133.70 (d; JC,P = 11.9 and
1
(s, C-31), 28.06 (s, C-28), 30.20 (s, C-27), 30.73 (d, JC,P = 22.9 Hz,
1
14.4 Hz, respectively; C-14, C-18, C-20 and C-24), 133.71 (d, JC,P
C-11), 35.60 (s, C-32), 38.89 (s, C-25), 55.83 (s, C-33), 67.42 (s, C-
3), 70.24 (s, C-6–C-10), 71.48 (s, C-4), 72.39 (s, C-5), 78.83 (d, 3JC,P
= 4.1 Hz, C-2), 81.86 (s, C-26) (C-1, overlapped signal), 122.37 (d,
= 46.3 Hz, C-13 and C-19), 175.09 (s, C-12) ppm. 31P{1H} NMR
(161.98 MHz, CD2Cl2, 25 °C): δ = 17.34 ppm.
2
Synthesis of 2c: A procedure analogous to that described above for
2a with HLc instead of HLa was employed to give 2c as an orange
crystalline solid. Yield 110.4 mg (74%). C36H37FeO3PPd (710.9):
calcd. C 60.85, H 5.21; found C 60.98, H 5.34. Diastereoisomer
ratio A/B = 3:1. Diasteroisomer A: 1H NMR (400.16 MHz,
2JC,P = 7.3 Hz, C-30), 124.57 (d, JC,P = 4.8 Hz, C-29), 128.67 and
3
3
128.03 (d; JC,P = 10.9 and JC,P = 9.7 Hz, respectively; C-15, C-
17, C-21 and C-23), 130.52 (br. s, C-16 and C-22), 131.40 and
134.80 (d; JC,P = 10.3 and 12.9 Hz, respectively; C-14, C-18, C-20
and C-24) (C-13 and C-19, overlapped signals), 176.29 (s, C-12)
ppm. 31P{1H} NMR (161.98 MHz, CD2Cl2, 25 °C): δ = 30.17 ppm.
Diasteroisomer B: 1H NMR (400.13 MHz, CD2Cl2, 25 °C): δ =
1.68–2.68 (9 H; 25-H, 27-H, 28-H, 31-H and 32-H), 2.41 (s, 3 H,
33-H), 3.30 (dd, 2JH,P = 14.4 and 2JH,H = 13.0 Hz, 1 H, 11-H), 3.96
2
3
CD2Cl2, 25 °C): δ = 1.05 (t, JH,H = 7.0 Hz, 3 H, 36-H), 1.18 (dd,
3
2
2JH,H = 7.2 and JH,H = 1.2 Hz, 1 H, 29-H), 1.37 (dd, JH,H = 9.9
3
and JH,H = 1.5 Hz, 1 H, 29Ј-H), 1.91 (m, 2 H, 32-H), 2.38 (d,
2JH,H = 5.5 Hz, 33-H), 2.70–2.92 (5 H, 11-H, 27-H and 34-H), 2.94
2
2
(m, 1 H, 28-H), 3.04 (m, 1 H, 26-H), 3.19 (m, 1 H, 35-H), 3.38 (m, (s, 1 H, 4-H), 4.03 (dd, JH,P = 7.4 and JH,H = 13.0 Hz, 1 H, 11Ј-
1 H, 35Ј-H), 3.52 (m, 1 H, 3-H), 3.61 (m, 1 H, 25-H), 4.12 (s, 5 H, H), 4.13 (s, 5 H, 6-H–10-H), 4.16 (br. s, 1 H, 5-H), 4.90 (br. s, 1 H,
6-H–10-H), 4.28 (t, 3JH,H = 2.5 Hz, 1 H, 4-H), 4.55 (m, 1 H, 5-H), 3-H), 6.26 (m, 1 H, 30-H) (29-H, overlapped signal), 7.22–7.92 (m,
6.55 (m, 1 H, 31-H), 7.57 (m, 1 H, 30-H), 7.35–7.75 (m, overlapping
signals, 14-H–18-H and 20-H–24-H) ppm. 13C{1H} NMR
(100.62 MHz, CD2Cl2, 25 °C): δ = 15.47 (s, C-36), 31.82 (s, C-34),
35.63 (s, C-29), 37.90 (s, C-27), 39.29 (s, C-11), 41.88 (s, C-33),
51.04 (s, C-32), 53.0 (s, C-26), 57.27 (s, C-28), 63.73 (s, C-35), 68.58
14-H–18-H and 20-H–24-H) ppm.13C{1H} NMR (100.62 MHz,
CD2Cl2, 25 °C): δ = 25.28 (s, C-31), 28.53 (s, C-28), 30.79 (s, C-
27), 31.34 (d, JP,C = 23.7 Hz, C-11), 35.15 (s, C-32), 38.35 (s, C-
1
25), 55.18 (s, C-33), 67.47 (s, C-3), 70.45 (s, C-6–C-10), 71.91 (s, C-
4), 72.89 (s, C-5), 78.84 (d, 3JC,P = 4.1 Hz, C-2), 81.69 (s, C-26) (C-
450
www.eurjic.org
© 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Inorg. Chem. 2008, 441–452